Fan Tong

1.9k total citations
50 papers, 1.5k citations indexed

About

Fan Tong is a scholar working on Biomedical Engineering, Oncology and Molecular Biology. According to data from OpenAlex, Fan Tong has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Biomedical Engineering, 16 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Fan Tong's work include Nanoplatforms for cancer theranostics (17 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Nanoparticle-Based Drug Delivery (9 papers). Fan Tong is often cited by papers focused on Nanoplatforms for cancer theranostics (17 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Nanoparticle-Based Drug Delivery (9 papers). Fan Tong collaborates with scholars based in China, Russia and South Korea. Fan Tong's co-authors include Huile Gao, Ting Lei, Yang Zhou, Lin Qin, Rou Xie, Chuan Hu, Jun Cao, Rui Liu, Zhihang Yang and Xiaotong Yang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Fan Tong

43 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fan Tong China 22 884 511 501 330 235 50 1.5k
Simmyung Yook South Korea 27 749 0.8× 599 1.2× 517 1.0× 286 0.9× 272 1.2× 78 1.9k
Rou Xie China 16 787 0.9× 626 1.2× 523 1.0× 204 0.6× 148 0.6× 17 1.4k
Yisi Tang China 14 591 0.7× 550 1.1× 557 1.1× 350 1.1× 234 1.0× 19 1.4k
Wenqi Yu China 18 1.2k 1.4× 913 1.8× 707 1.4× 215 0.7× 181 0.8× 22 1.9k
Janet L. Markman United States 15 372 0.4× 429 0.8× 581 1.2× 351 1.1× 382 1.6× 21 1.5k
Huamei He China 19 1.2k 1.4× 283 0.6× 509 1.0× 420 1.3× 189 0.8× 28 1.9k
Anubhab Mukherjee United States 12 609 0.7× 450 0.9× 688 1.4× 212 0.6× 371 1.6× 18 1.8k
Hongyue Jin China 10 459 0.5× 513 1.0× 557 1.1× 215 0.7× 171 0.7× 10 1.2k
Lu Tang China 20 633 0.7× 337 0.7× 431 0.9× 146 0.4× 115 0.5× 44 1.2k
Wenquan Ou South Korea 22 793 0.9× 523 1.0× 544 1.1× 344 1.0× 243 1.0× 34 1.5k

Countries citing papers authored by Fan Tong

Since Specialization
Citations

This map shows the geographic impact of Fan Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fan Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fan Tong more than expected).

Fields of papers citing papers by Fan Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fan Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fan Tong. The network helps show where Fan Tong may publish in the future.

Co-authorship network of co-authors of Fan Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Fan Tong. A scholar is included among the top collaborators of Fan Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fan Tong. Fan Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaorong, et al.. (2025). Challenges and strategies for nose-to-brain delivery in treating neurological disorders. Expert Opinion on Drug Delivery. 23(2). 313–332.
2.
Xu, Yanyan, Wenqin Yang, Fan Tong, et al.. (2025). Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy. Acta Pharmaceutica Sinica B. 15(6). 2884–2899. 12 indexed citations
3.
Sun, Jiayi, Leyi Huang, Wenfeng Jia, et al.. (2025). Nanodelivery strategies modulating tumor stromal cells for reverting the immunosuppressive tumor microenvironment. Chinese Chemical Letters. 37(4). 112036–112036.
4.
Tang, Ning, Fan Tong, Lulu Wang, et al.. (2025). Glutathione/Cysteine Dual‐Consuming Prodrug Nanoassemblies for Potentiated Gas‐Photodynamic Therapy. Advanced Functional Materials. 35(37). 1 indexed citations
5.
Du, Juan, Huizi Sha, Fan Tong, et al.. (2025). Personalized ctDNA monitoring to assess the recurrence of early stage pancreatic cancer after surgery.. Journal of Clinical Oncology. 43(4_suppl). 774–774. 1 indexed citations
6.
Wang, Qin, Fan Tong, Qiao Li, et al.. (2024). Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic cancer: a single-arm, phase II clinical trial. Cancer Immunology Immunotherapy. 73(10). 201–201. 2 indexed citations
7.
Huang, Zhe, Liang Zeng, Qinqin Xu, et al.. (2024). Development of a prognostic nomogram for advanced non-small cell lung cancer using clinical characteristics. iScience. 27(10). 110910–110910.
8.
Tong, Fan, Yanyan Xu, Yang Zhou, et al.. (2024). MMP-2-triggered, mitochondria-targeted PROTAC-PDT therapy of breast cancer and brain metastases inhibition. Nature Communications. 15(1). 10382–10382. 28 indexed citations
9.
Zhang, Weiwei, Lei Lei, Fan Tong, et al.. (2023). Combination losartan with hyaluronic acid modified diethyldithiocarbamate loaded hollow copper sulfide nanoparticles for the treatment of breast cancer and metastasis. Chinese Chemical Letters. 35(3). 108765–108765. 28 indexed citations
10.
Tong, Fan, Yang Zhou, Yanyan Xu, et al.. (2023). Supramolecular nanomedicines based on host–guest interactions of cyclodextrins. SHILAP Revista de lepidopterología. 3(4). 20210111–20210111. 42 indexed citations
11.
Dong, Xiaorong, Fan Tong, Yunyi Kong, et al.. (2023). EP13.07-09 The Role of Radiotherapy in Extensive-Stage Small Cell Lung Cancer after Durvalumab-Based Immunochemotherapy: A Retrospective Study. Journal of Thoracic Oncology. 18(11). S710–S710.
12.
Li, Zhaofeng, Peixin Liu, Wei Chen, et al.. (2023). Hypoxia-cleavable and specific targeted nanomedicine delivers epigenetic drugs for enhanced treatment of breast cancer and bone metastasis. Journal of Nanobiotechnology. 21(1). 221–221. 21 indexed citations
13.
16.
Zeng, Hao, Fan Tong, Ling Peng, et al.. (2022). The Predictive Value of PAK7 Mutation for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Cancer. Frontiers in Immunology. 13. 834142–834142. 6 indexed citations
17.
He, Yanmei, Jun Cao, Xiaotong Yang, et al.. (2021). A combinational chemo-immune therapy using an enzyme-sensitive nanoplatform for dual-drug delivery to specific sites by cascade targeting. Science Advances. 7(6). 123 indexed citations
18.
Xiong, Yuxuan, Fei Sun, Zhe Yang, et al.. (2018). Polydopamine-mediated bio-inspired synthesis of copper sulfide nanoparticles for T1-weighted magnetic resonance imaging guided photothermal cancer therapy. Colloids and Surfaces B Biointerfaces. 173. 607–615. 31 indexed citations
19.
Chen, Weijie, et al.. (2016). Effect of leading-edge serrations on boundary layer instability noise. 37(12). 3645.
20.
Li, Jie, et al.. (2003). Modulations by cAMP and cGMP of the high-voltage activated Ca~(2+) channels in the central neurons of the cotton bollworm, Helicoverpa armigera. 47(4). 429–433. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026